Related Experiment Video

Updated: May 22, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Roles of 14-3-3η in mitotic progression and its potential use as a therapeutic target for cancers

C G Lee1, G-Y Park, Y K Han

  • 1Research Center, Dongnam Institute of Radiological and Medical Sciences, Busan, Korea. cglee@dirams.re.kr

Oncogene
|May 8, 2012
PubMed

Insights

Depleting 14-3-3η protein enhances cancer cell death during mitosis, increasing sensitivity to microtubule inhibitors and reducing aneuploidy. This suggests 14-3-3η is crucial for mitotic progression.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • 14-3-3 proteins regulate cell cycle transitions like G1/S and G2/M.
  • The specific roles of 14-3-3 proteins during mitosis remain unclear.
  • Mitotic cell death and aneuploidy are critical in cancer progression.

Purpose of the Study:

  • To investigate the role of 14-3-3η during mitosis.
  • To determine if 14-3-3η influences mitotic cell death and aneuploidy.
  • To evaluate the potential of targeting 14-3-3η in cancer therapy.

Main Methods:

  • Depletion of 14-3-3η using RNA interference or other methods.
  • Assessment of mitotic cell death (caspase-dependent and independent pathways).
  • Analysis of aneuploidy formation and mitotic checkpoint function.
  • Treatment of cancer cell lines (HCT116, U87MG) with microtubule inhibitors with or without 14-3-3η depletion.

Main Results:

  • 14-3-3η depletion significantly enhanced mitotic cell death.
  • Depletion of 14-3-3η led to reduced aneuploidy formation.
  • Enhanced mitotic cell death and reduced aneuploidy were independent of the mitotic checkpoint.
  • Combined depletion of 14-3-3η and treatment with microtubule inhibitors sensitized cancer cells to the drugs.

Conclusions:

  • 14-3-3η plays a significant role in ensuring proper mitotic progression.
  • Targeting 14-3-3η can induce mitotic cell death and inhibit aneuploidy.
  • 14-3-3η inhibition, in combination with microtubule inhibitors, represents a promising anti-cancer strategy.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...